The bacterial LPS will be recognized as an immunogenic PAMPs by PRRs to promote the M1 polarization of TAMs and induce the maturation of immature DCs (iDCs) via the TLR4–MyD88–NF-κB pathway, finally activating T effector cells and triggering the integrated immunity to kill tumor cells. The gene discussed is TLR4; the disease is neoplasm.